Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check8 days agoChange DetectedA note was added to Publications clarifying that publications are provided voluntarily by the person entering study information and pertain to the study results, and the Revision label was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange DetectedTwo new trial locations in Tainan, Taiwan (postal codes 704 and 736) were added. The existing Tainan City entries for 704 and 736 were renamed to 'Tainan, Taiwan' with the same postal codes.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedNo significant substantive changes detected; only minor formatting differences are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed the specific resource “Small cell lung carcinoma” from the Genetic and Rare Diseases Information Center.SummaryDifference2%

- Check60 days agoChange Detected- Added: Revision: v3.1.0. - Removed: Genetic and Rare Diseases Information Center resources: Small cell lung carcinoma and Revision: v3.0.2. The page now references a newer version tag and drops one specific resource entry; core content remains largely unchanged.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.